...
首页> 外文期刊>IFAC PapersOnLine >Comparison of modulated and clinically set nutrition protocol’s for STAR
【24h】

Comparison of modulated and clinically set nutrition protocol’s for STAR

机译:调制与临床设置营养方案的比较

获取原文

摘要

Introduction: Hyperglycaemia is common in intensive care units (ICU’s) and is associated with negative clinical outcomes. One ICU aim is to provide the highest nutrition possible, while achieving normo-glycaemic blood glucose (BG) levels. The best nutrition delivery method and amount is controversial and highly debated. STAR is a proven glucose control (GC) method providing nutrition at or near to that achieved by the best ICU’s in the world, while also achieving safe and effective GC. This study analyses the key outcomes of STAR’s modulated insulin and nutrition protocol (STAR), and a clinically set nutrition protocol with STAR’s insulin only control (STAR-IO). This comparison separates the effect of controlling insulin and nutrition, vs using insulin alone to control glucose.Methods: BG measurements for patients treated with STAR (N = 221; 2011 - 2015) and STAR-IO (N = 194; 2016 - 2017) are evaluated for GC performance, safety, and workload. Mean nutrition delivery over the first 7 days of ICU stay for both cohorts was analysed, including assessment of unfed hours.Results: Patient cohorts were similar in age, sex and length of GC (median ~ 2days). The BG levels achieved by STAR were significantly lower than STAR-IO (median 6.8 vs 7.9 mmol/L, P < 0.05). 34% more BG measurements were in the normo-glycaemic range (4.0 - 8.0 mmol/L) for STAR. %BG < 4.0 mmol/L was very low in both cases indicating equivalent safety. STAR’s nutrition delivery rates were 63% and 20% higher, respectively, on the first 2 days of ICU stay than under STAR-IO. After 2 days, nutrition delivery rates were within 9% but STAR remained higher. Additionally, under STAR only 14.4% hours of treatment on GC were unfed compared to STAR-IO’s 22.3% (P < 0.05). STAR-IO required approximately 4 more BG measurements (+ 30%) on average per day than STAR (16.5 vs 12.7 measures/day).Conclusions: STAR’s modulated insulin and nutrition protocol resulted in better GC performance, and equivalent safety, with far lower workload. It also delivered significantly higher nutrition on the first 2 days of ICU stay, where median time on GC is 2.2 days and STAR had 55% less unfed hours than STAR-IO.
机译:简介:高血糖症在重症监护单位(ICU)中是常见的,并且与阴性临床结果有关。一个ICU的目标是提供最高的营养,同时实现常规血糖血糖(BG)水平。最好的营养交付方法和金额是有争议的和高度辩论。 STAR是一项经过验证的葡萄糖控制(GC)方法,在世界上最好的ICU实现或附近提供营养,同时也实现了安全有效的GC。本研究分析了明星调节胰岛素和营养方案(明星)的关键结果,以及临床营养方案,与明星的胰岛素仅控制(Star-IO)。这种比较分离控制胰岛素和营养的效果,VS使用胰岛素控制葡萄糖。方法:用星(N = 221; 2011 - 2015)和星IO(n = 194; 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016 - 2016年)评估GC性能,安全性和工作负载。平均营养交付在ICU的前7天内分析了两个队列,包括对不断的小时数的评估。结果:患者队列在年龄,性别和GC的长度相似(中位数〜2天)。恒星实现的BG水平明显低于星 - IO(中位数6.8 Vs 7.9 mmol / L,P <0.05)。 BG测量的34%在Normo-血糖范围内(4.0-8.0mmol / L),用于明星。两种情况下,%BG <4.0 mmol / L非常低,指示等效安全性。在ICU停留的前2天,星星的营养交付率分别为63%和20%,而不是明星-IO。 2天后,营养交付率在9%以内,但明星仍然更高。此外,与星际IO的22.3%相比,在GC的恒星下仅14.4%的疗法术语不开放(P <0.05)。 STAR-IO每天平均约4个BG测量(+ 30%),而不是明星(16.5 Vs 12.7措施/日)。结论:明星的调节胰岛素和营养方案导致GC性能更好,等效的安全性,远低得多工作量。它还在ICU的前2天内提供了明显更高的营养,其中GC的中位数时间为2.2天,星星比星形IO不断减少55%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号